Commission Delegated Directive on isotonitazene

Original/alternative title

Commission Delegated Directive (EU) 2020/1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimid

Summary 

Isotonitazene is a synthetic opioid analgesic and is closely related to etonitazene and clonitazene, both of which are under international control under the 1961 United Nations Single Convention on Narcotic Drugs, as amended by the 1972 Protocol. This document is the Commission Delegated Directive (EU) 2020/1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004/757/JHA as regards the inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of ‘drug’.

PDF download

PDF files are made available as a convenience. In cases where the EMCDDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoratative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.

CELEX_32020L1687_EN_TXT.pdf
multilingual
document cover
Organisation (author) 
Council of the European Union
Category EU law
Date 13 November 2020
Access
Open access
Publisher's DOI:
http://data.europa.eu/eli/dir_del/2020/1687/oj
Document language
Bulgarian,
Croatian,
Czech,
Danish,
Dutch,
English,
Estonian,
Finnish,
French,
German,
Greek,
Hungarian,
Italian,
Latvian,
Lithuanian,
Maltese,
Polish,
Portuguese,
Romanian,
Slovakian,
Slovene,
Spanish,
Swedish
Loading